Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We have in a pilot study found that serum calcium levels change in response to hCG stimulation test. We observed that serum calcium level measured at baseline and 72 hours after hCG stimulation were different in men with gonadal insufficiency referred for this stimulation test. Now we want to investigate a large cohort of men referred for hCG stimulation test due to suspected impaired gonadal function.
Introduction:
hCG signals through the LHCGR receptor and is know to stimulate testosterone production. hCG stimulation tests are therefore used to evaulate the capacity of the testis to respond to LH/hCG and thereby determine the degree og gonadal insufficiency and need for testosterone supplementation. Some groups have found LHCRG in extragondal tissues indicating a direct effect of hCG/LH outside the gonads. We noticed that some men with gonadal insuffciency had a low calcium level after hCG stimulation test. Now we would like to investigate whether this putative effect on calcium homeostasis of hCG is due to a direct effect or an indirect effect through testosterone or other sex steroids that also change in response to hCG stimulation. Moreover, we would like to clarify whether the chnage in calcium is compensated by classical regulators such as PTH, 1,25OH2D3, calcitonin, phosphate, CTX, alkaline phosphatase or other factors.
Aim of study:
The purpose of this study is to describe changes in calcium and calciotropic hormones after hCG stimulation test
DESIGN This is a prospective observational study
Patients and methods 100 men referred for hCG stimulation test due to suspected gonadal insuffciency age 18-60 years at Department of growth and reproduction, Rigshospitalet
Exclusion criteria are
intake of high dose calcium (above 1 mg daily) Known Disorders related to calcium metabolism, hypercalcemia, Granulomatous disease such as Wegener, tuberculosis, etc,
SAMPLE SIZE CALCULATION AND STATISTICS By using a test level of 5% (level of significance), power of 80% and at least 100 men completing the trial will enable us to detect a change in calcium of 10%, and a change in serum PTH of 30%.
SCREENING AND TIME COURSE Men referred for hCG stimulation test at ourDepartment will be screened for eligibility to the study. Those who meet the criteria for participation will be informed, and if they consent allocated to the study.
Each person will have one blood sampling performed prior to the test and 72 and 96 hours after the test.
Blood samples Venus blood is drawn preoperatively before hCG administration, 72 and 96 hours after. Serum will be send for analysis within 45 minutes and the rest frozen within 1 hour and will be stored at minus 20 degrees celsius until analysis.
OUTCOME MEASUREMENTS
Primary endpoints
•Changes in total, albumin corrected and ionized calcium
Main Secondary endpoints
Temporal changes in serum level of binding proteins. differences for vitamin D binding protein, albumin and sex hormone binding globulin.
Predefined subgroups orchiectomized men/ bilaterally irradiated testis High versus low baseline estradiol/testosterone Low/high calcium/PTH baseline
ANALYSIS AND INTERVENTION
Reproductive hormones and growth factors will be analysed at dept. of GR, Rigshospitalet. Other serum analyses will be analysed at Department of clinical biochemistry, and Aarhus Kommune Hospital
ETHICS AND SIDE EFFECTS All the patients will have full-filled their investigation, before they are invited to the study. They will be informed of potential adverse effects, and they can leave the trial at any point without any consequences. This study poses no additional risk to the patients except for the blood samples as everything else is according to standard clinical practice.
PUBLICATION OF RESULTS All results, positive or negative will be submitted to peer reviewed scientific journals. Data will successively be obtained and transferred to a statistical database.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| hypogondal men | men referred for hCG stimulation test |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| human chorionic gonadotropin | Drug | 5000 IE times one |
|
| Measure | Description | Time Frame |
|---|---|---|
| change in total, albumin corrected or ionized calcium | mmol/l | 72 and 96 hours after hCG injection |
| Measure | Description | Time Frame |
|---|---|---|
| PTH | 72 and 96 hours after hCG injection | |
| 1,25OH2D3 | 72 and 96 hours after hCG injection | |
| Phosphate |
Not provided
Inclusion Criteria:
- men aged 18-60 years referred for hCG stimulation test due to previous treatment for testis cancer
Exclusion Criteria:
referred for hCG stimulation test
men with suspected gonadal i suffciency ofter after orchiectomy or bilateral irradiation due to testis cancer
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Growth and Reproduction, Rigshospitalet | Copenhagen | 2100 | Denmark | |||
| Rigshospitalet |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38852333 | Derived | Juel Mortensen L, Kooij I, Lorenzen M, Rye Jorgensen N, Roder A, Jorgensen A, Andersson AM, Juul A, Blomberg Jensen M. Injection of luteinizing hormone or human chorionic gonadotropin increases calcium excretion and serum PTH in males. Cell Calcium. 2024 Sep;122:102908. doi: 10.1016/j.ceca.2024.102908. Epub 2024 May 24. |
Not provided
Not provided
share all available data through danish data archive
2 years after study completion
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D005058 | Eunuchism |
| ID | Term |
|---|---|
| D007006 | Hypogonadism |
| D006058 | Gonadal Disorders |
| D004700 | Endocrine System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D006063 | Chorionic Gonadotropin |
| ID | Term |
|---|---|
| D006062 | Gonadotropins |
| D036361 | Peptide Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
Not provided
Not provided
Not provided
Not provided
Not provided
serum
| 72 and 96 hours after hCG injection |
| cortisol | 72 and 96 hours after hCG injection |
| total and free testosterone | 72 and 96 hours after hCG injection |
| total and free estradiol | 72 and 96 hours after hCG injection |
| albumin, Shbg, VDBP | 72 and 96 hours after hCG injection |
| 25OHD or 24,25OH2D3 | 72 and 96 hours after hCG injection |
| bone factors such as CTX, osteocalcin, RANKL, FGF23 | 72 and 96 hours after hCG injection |
| LHCGR | in serum | 72 and 96 hours after hCG injection |
| kidney function | eGFR/creatinine | 72 and 96 hours after hCG injection |
| Copenhagen |
| 2100 |
| Denmark |
| D010926 | Placental Hormones |
| D010455 | Peptides |
| D000602 | Amino Acids, Peptides, and Proteins |
| D011257 | Pregnancy Proteins |
| D011506 | Proteins |